Metformin Hydrochloride Rxfarma (Metformin Hydrochloride)

Metformin Hydrochloride reduces the liver’s production of glucose, decreases intestinal absorption of sugar, and enhances the body’s response to insulin. By activating AMP‑activated protein kinase (AMPK), it promotes the uptake of glucose into muscle cells, helping to lower overall blood‑glucose levels.

The dosage of Metformin Hydrochloride Rxfarma is individualized by the prescribing clinician based on the patient’s medical condition, renal function, and response to therapy. The prescriber determines the appropriate strength, frequency, and titration schedule.

Safety of Metformin Hydrochloride in pregnancy or while breastfeeding has not been definitively established. Healthcare providers weigh potential benefits against possible risks before prescribing it to pregnant or nursing women, and it should only be used if clearly indicated.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Metformin Hydrochloride belongs to the biguanide class and is often first‑line therapy for type 2 diabetes because it does not cause weight gain and has a low risk of hypoglycemia when used alone. Compared with sulfonylureas or insulin, it works primarily by reducing hepatic glucose output rather than stimulating insulin secretion.

Store Metformin Hydrochloride Rxfarma at ambient temperature, preferably below 25 °C, in its original container to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date printed on the packaging.

Metformin Hydrochloride is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a full glass of water; they are not intended to be crushed, chewed, or dissolved unless specifically instructed by a healthcare professional.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal impairment, liver disease, or excessive alcohol intake. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Metformin Hydrochloride is contraindicated in individuals with severe renal dysfunction (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, known hypersensitivity to metformin, or those who are currently receiving iodinated contrast media. Patients with these conditions should discuss alternative therapies with their clinician.